MeHow Innovative Past Earnings Performance
Past criteria checks 2/6
MeHow Innovative has been growing earnings at an average annual rate of 2.9%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 10.6% per year. MeHow Innovative's return on equity is 8%, and it has net margins of 18.7%.
Key information
2.9%
Earnings growth rate
-1.1%
EPS growth rate
Medical Equipment Industry Growth | 16.0% |
Revenue growth rate | 10.6% |
Return on equity | 8.0% |
Net Margin | 18.7% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Returns On Capital Signal Tricky Times Ahead For MeHow Innovative (SZSE:301363)
Sep 27MeHow Innovative's (SZSE:301363) Dividend Is Being Reduced To CN¥0.16
Jun 03MeHow Innovative Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Apr 21Calculating The Intrinsic Value Of MeHow Innovative Ltd. (SZSE:301363)
Apr 01Mehow Innovative (SZSE:301363) Will Be Hoping To Turn Its Returns On Capital Around
Feb 26Revenue & Expenses Breakdown
How MeHow Innovative makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 1,451 | 271 | 156 | 144 |
30 Jun 24 | 1,290 | 242 | 145 | 125 |
31 Mar 24 | 1,252 | 263 | 154 | 122 |
31 Dec 23 | 1,338 | 313 | 146 | 120 |
30 Sep 23 | 1,391 | 375 | 131 | 108 |
30 Jun 23 | 1,495 | 457 | 133 | 103 |
31 Mar 23 | 1,498 | 443 | 118 | 91 |
01 Jan 23 | 1,415 | 402 | 110 | 88 |
30 Sep 22 | 1,381 | 401 | 98 | 79 |
30 Jun 22 | 1,303 | 363 | 121 | 101 |
31 Mar 22 | 1,168 | 311 | 97 | 81 |
01 Jan 22 | 1,137 | 310 | 81 | 64 |
31 Dec 20 | 888 | 258 | 78 | 49 |
31 Dec 19 | 742 | 232 | 62 | 41 |
31 Dec 18 | 582 | 131 | 76 | 33 |
Quality Earnings: 301363 has high quality earnings.
Growing Profit Margin: 301363's current net profit margins (18.7%) are lower than last year (27%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 301363's earnings have grown by 2.9% per year over the past 5 years.
Accelerating Growth: 301363's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 301363 had negative earnings growth (-27.8%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.8%).
Return on Equity
High ROE: 301363's Return on Equity (8%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 21:34 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
MeHow Innovative Ltd. is covered by 10 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Zhu Chen | Citic Securities Co., Ltd. |
Shuo Song | Citic Securities Co., Ltd. |
Xiao Wei Lin | Everbright Securities Co. Ltd. |